Tag: data

HAMPTON, N.J., June 14, 2025 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced data demonstrating that barzolvolimab profoundly improves angioedema at 52 weeks in the Company’s Phase 2 clinical trial in chronic spontaneous urticaria (CSU). Angioedema, characterized by swelling of the deeper dermal layers of the skin and mucous membranes, is a painful, debilitating symptom of CSU that has significant impact on quality of life. It commonly affects the face (lips and eyelids), hands, feet, and genitalia but can also involve the tongue, uvula, soft palate, and pharynx¹.

11 of 12 participants (92%) enrolled in the 180mg cohort achieved a complete response

As PFMCrypto’s AI-driven mining model gains momentum, the platform celebrates a major milestone with a global bonus campaign for new users

DENVER, June 14, 2025 (GLOBE NEWSWIRE) -- As more countries begin to establish regulatory frameworks for cryptocurrencies, Zinemx Exchange has released updates on its multinational market strategy, accelerating compliance efforts in Asian and European markets and planning to set up additional offices in more regions. Recognizing the differences in crypto regulatory policies across countries, Zinemx will actively comply with local laws to provide compliant and secure crypto trading services to investors in more regions.

DENVER, June 14, 2025 (GLOBE NEWSWIRE) -- Recently, Zinemx Exchange upgraded its trading system by adopting a new high-performance matching engine, significantly improving order matching efficiency and delivering a more efficient trading experience for users. The distributed architecture and intelligent optimization algorithms enable millisecond-level latency and support the processing of millions of concurrent orders, ensuring stable trade execution even during periods of high market volatility.

DENVER, June 14, 2025 (GLOBE NEWSWIRE) -- Recently, BACXN has passed compliance regulatory reviews in North America and Southeast Asia, officially launching a cross-jurisdictional risk control and compliance response mechanism. This milestone signifies that the platform not only possesses the qualifications for global operations but has also entered a verifiable and sustainable “deep compliance zone” in its institutional framework. This is not a short-term compliance showcase, but a core part of the long-term trust strategy of BACXN.